INCURRED SAMPLE STABILITY OF METFORMIN HYDROCHLORIDE IN PLASMA OF SIX HEALTHY SUBJECTS USING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY

Authors

  • Yahdiana Harahap Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia.
  • Ferry Ivan Balto Suwanto Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia.
  • Sunarsih . Faculty of Pharmacy, Universitas Indonesia, Depok, 16424, Indonesia.

DOI:

https://doi.org/10.22159/ijap.2018.v10s1.58

Keywords:

High-performance liquid chromatography, Human plasma, Incurred sample, Metformin hydrochloride, Partial validation

Abstract

Objective: This study aimed to measure metformin levels and evaluates the incurred stability in plasma of six healthy subjects after administration
850 mg metformin hydrochloride tablet using high-performance liquid chromatography.
Methods: Samples were collected from six healthy subjects who were administered 850 mg metformin hydrochloride tablet. Blood was collected from
the subjects at up to 12-time points throughout a 12 h period. Sample stability was analyzed on days 7, 14, and 30. The analysis was conducted using
C-18 columns, a column temperature of 40°C, a mobile phase consisting of acetonitrile-phosphate buffer (pH 7.0; 40:60 v/v), a flow rate of 1 mL/min,
the photodiode array detector set at a wavelength of 234 nm, and calcium atorvastatin as the internal standard.
Results: All metformin HCl samples collected on days 7, 14, and 30 from subjects 1 to 6 met stability requirement based on the European Medicines
Agency Bioanalytical Guideline (2011), which state that the percentage difference value not >20%. In addition, the developed method for analyzing
metformin HCl in plasma was linear in the concentration range of 20.0–5000.0 ng/mL (r=0.9999).
Conclusion: The incurred sample of metformin hydrochloride in plasma of six healthy subjects was stable until 30 days after drug administration.

Downloads

Download data is not yet available.

References

Katzung BG. Basic and Clinical Pharmacology. UK: McGraw-Hill

Companies; 2003.

DiPiro JT, Talbert RL, Yee G, Matzke G, Wells B, Posey LM.

Pharmacotherapy. A Pathophysiologic Approach. 7th ed. United States

of America: McGraw-Hill; 2008.

Diwedi R, Alexandar S, Chandrasekar MJ. Preparation and in vitro

evaluation of sustained release tablet formulations of metformin HCL.

Asian J Pharm Clin Res 2012;5:45-8.

Ingle PV, Talele GS. Adverse effects of metformin in combination

with glimepiride and glibenclamide in patients with Type 2 diabetes

mellitus. Asian J Pharm Clin Res 2012;5:108-10.

Indonesian National Agency of Food and Drug Control. Regulation

from Head of No. HK.03.1.23.12.11.10217 about Drug Obligate

Equivalence Study Jakarta; 2011.

Rout SP, Kar DM, Mohapatra SB, Swain SP. Anti-hyperglycemic effect

Annova reticulata L. Leaves on experimental diabetic rat model. Asian

J Pharm Clin Res 2013;6:56-60.

European Medicines Agency. Guideline on Bioanalytical Method

Validation. Vol. 44. London: An Agency of the European Union; 2011.

Food and Drug Administration. Guidance for Industry Bioanalytical

Method Validation. United States of America: Department of Health

and Human Services; 2015.

Lowes S, LeLacheur R, Shoup R, Garofolo F, Dumont I, Martinez S,

et al. Recommendations on incurred sample stability (ISS) by GCC.

Bioanalysis 2014;6:2385-90.

Aburuz S, Millership J, McElnay J. Dried blood spot liquid

chromatography assay for the therapeutic drug monitoring of

metformin. J Chromatogr B Analyt Technol Biomed Life Sci

;832:202-7.

Published

20-12-2018

How to Cite

Harahap, Y., Suwanto, F. I. B., & ., S. (2018). INCURRED SAMPLE STABILITY OF METFORMIN HYDROCHLORIDE IN PLASMA OF SIX HEALTHY SUBJECTS USING HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY. International Journal of Applied Pharmaceutics, 10(1), 260–263. https://doi.org/10.22159/ijap.2018.v10s1.58

Issue

Section

Original Article(s)

Most read articles by the same author(s)

<< < 1 2 3 > >>